Matches in Nanopublications for { ?s ?p "Finally, simulations were performed to predict the antitumor efficacy of dexamethasone (DEX) combined with dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) under various dose regimens, where changing dosing frequency of dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) had little effect, while the antitumor efficacy of DEX combined with SUL was predicted to be improved when dexamethasone (DEX) was given more frequently." ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- SENTENCE label "Finally, simulations were performed to predict the antitumor efficacy of dexamethasone (DEX) combined with dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) under various dose regimens, where changing dosing frequency of dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) had little effect, while the antitumor efficacy of DEX combined with SUL was predicted to be improved when dexamethasone (DEX) was given more frequently." provenance.
- SENTENCE label "Finally, simulations were performed to predict the antitumor efficacy of dexamethasone (DEX) combined with dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) under various dose regimens, where changing dosing frequency of dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) had little effect, while the antitumor efficacy of DEX combined with SUL was predicted to be improved when dexamethasone (DEX) was given more frequently." provenance.